Effects of Aerobidol® Inhaler on pulmonary function in COPD patients

Not Applicable

• Conditions: chronic obstructive pulmonary disease; Aerobidol; COPD; pulmonary function; FEV1; RV

• Registration Number: TCTR20150210001
• Lead Sponsor: AeroCare Co.,Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-02-10
• Study Completion: 2015-10-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 31

Inclusion Criteria

Patients aged more than 40 years, smoking more than 10 packyears who diagnosed with COPD by spirometry (post bronchodilator FEV1/FVC less than 70%)

Exclusion Criteria

Patients who cannot perform body plethysmography
COPD patients who have medical disease such as lung cancer, bronchiectasis, severe tracheobronchomalacia
Patients who refuse to join the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
FEV1, FVC, IC, RV, TLC 2 (pre-,post-) body plethysmography

Secondary Outcome Measures

Name	Time	Method
satisfaction score, side effects 1 questionnaire